Literature DB >> 3185547

Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine.

J Filmus1, J G Church, R N Buick.   

Abstract

We report the isolation of a cDNA clone corresponding to a transcript that is accumulated differentially in rat intestine during development. Clone OCI-5 was selected from the rat intestinal cell line IEC-18, which represents primitive intestinal epithelial crypt cells. Expression was high in rat fetal intestine between 15 and 19 days of development and thereafter was progressively down regulated, becoming undetectable after weaning. Clone OCI-5 detected homologous sequences in human and murine cells. In particular, a high level of expression was detected in CaCo-2, a human colon carcinoma cell line, which is known to express molecules characteristic of fetal small intestinal cells. Expression of a homologous gene was also detected in F9 murine teratocarcinoma cells when they were induced to differentiate into parietal or visceral endodermlike cells. When IEC-18 cells were transformed by activated H-ras or v-src genes, expression of clone OCI-5 was suppressed; the degree of down-regulation correlated with the extent of morphological change induced in the transformed IEC-18 cells. The sequence of clone OCI-5 showed an open reading frame that was capable of encoding a protein of 597 amino acids, but no strong homology was found with any of the proteins registered in the protein sequence data base.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3185547      PMCID: PMC365496          DOI: 10.1128/mcb.8.10.4243-4249.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  Transformation of rat liver cell line by Rous sarcoma virus causes loss of cell surface fibronectin, accompanied with secretion of metallo-proteinase that preferentially digests the fibronectin.

Authors:  K Miyazaki; Y Ashida; Y Kihira; K Mashima; J Yamashita; T Horio
Journal:  J Biochem       Date:  1987-09       Impact factor: 3.387

2.  Morphogenesis of fetal rat duodenal villi.

Authors:  M Mathan; P C Moxey; J S Trier
Journal:  Am J Anat       Date:  1976-05

3.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

4.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell.

Authors:  H Cheng; C P Leblond
Journal:  Am J Anat       Date:  1974-12

5.  Intestinal epithelial cell surface membrane glycoprotein synthesis. II. Glycosyltransferases and endogenous acceptors of the undifferentiated cell surface membrane.

Authors:  M M Weiser
Journal:  J Biol Chem       Date:  1973-04-10       Impact factor: 5.157

6.  The effects of v-src expression on the differentiation of embryonal carcinoma cells.

Authors:  C A Boulter; E F Wagner
Journal:  Oncogene       Date:  1988-03       Impact factor: 9.867

7.  A human breast adenocarcinoma with chromosome and isoenzyme markers similar to those of the HeLa line.

Authors:  S Pathak; M J Siciliano; R Cailleau; C L Wiseman; T C Hsu
Journal:  J Natl Cancer Inst       Date:  1979-02       Impact factor: 13.506

8.  Activated H-ras transforms rat intestinal epithelial cells with expression of alpha-TGF.

Authors:  R N Buick; J Filmus; A Quaroni
Journal:  Exp Cell Res       Date:  1987-06       Impact factor: 3.905

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  DNA synthesis and proliferation by villous epithelial cells in fetal rats.

Authors:  J A Hermos; M Mathan; J S Trier
Journal:  J Cell Biol       Date:  1971-07       Impact factor: 10.539

View more
  30 in total

Review 1.  Glypicans: proteoglycans with a surprise.

Authors:  J Filmus; S B Selleck
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Activated T cells express a novel gene on chromosome 8 that is closely related to the murine ecotropic retroviral receptor.

Authors:  C L MacLeod; K Finley; D Kakuda; C A Kozak; M F Wilkinson
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

Review 3.  The contribution of in vivo manipulation of gene expression to the understanding of the function of glypicans.

Authors:  Jorge Filmus
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

4.  Mapping of the Simpson-Golabi-Behmel overgrowth syndrome gene (GPC3) to chromosome X in human and rat by fluorescence in situ hybridization.

Authors:  T Shen; G Sonoda; J Hamid; M Li; J Filmus; R N Buick; J R Testa
Journal:  Mamm Genome       Date:  1997-01       Impact factor: 2.957

Review 5.  Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma.

Authors:  Yukihiro Haruyama; Hiroaki Kataoka
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 6.  Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.

Authors:  Mitchell Ho
Journal:  BioDrugs       Date:  2011-10-01       Impact factor: 5.807

7.  Expression of glypican-4 in haematopoietic-progenitor and bone-marrow-stromal cells.

Authors:  B Siebertz; G Stöcker; Z Drzeniek; S Handt; U Just; H D Haubeck
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

8.  Glypican-3-mediated inhibition of CD26 by TFPI: a novel mechanism in hematopoietic stem cell homing and maintenance.

Authors:  Satish Khurana; Lia Margamuljana; Chacko Joseph; Sarah Schouteden; Shannon M Buckley; Catherine M Verfaillie
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

9.  GPC5 is a possible target for the 13q31-q32 amplification detected in lymphoma cell lines.

Authors:  Wei Yu; Jun Inoue; Issei Imoto; Yoshinobu Matsuo; Abraham Karpas; Johji Inazawa
Journal:  J Hum Genet       Date:  2003-04-29       Impact factor: 3.172

10.  The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.

Authors:  J Kleeff; T Ishiwata; A Kumbasar; H Friess; M W Büchler; A D Lander; M Korc
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.